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Abstract
Background: Animal studies have increasingly highlighted the role of macrophages in 
the development of delayed gastric emptying. However, their role in the pathophysiol-
ogy of human gastroparesis is unclear. Our aim was to determine changes in mac-
rophages and other cell types in the gastric antrum muscularis propria of patients with 
diabetic and idiopathic gastroparesis.
Methods: Full thickness gastric antrum biopsies were obtained from patients enrolled in the 
Gastroparesis Clinical Research Consortium (11 diabetic, 6 idiopathic) and 5 controls. 
Immunolabeling and quantitative assessment was done for interstitial cells of Cajal (ICC) 
(Kit), enteric nerves protein gene product 9.5, neuronal nitric oxide synthase, vasoactive 
intestinal peptide, substance P, tyrosine hydroxylase), overall immune cells (CD45) and anti- 
inflammatory macrophages (CD206). Gastric emptying was assessed using nuclear medi-
cine scintigraphy and symptom severity using the Gastroparesis Cardinal Symptom Index.
Results: Both diabetic and idiopathic gastroparesis patients showed loss of ICC as 
compared to controls (Mean [standard error of mean]/hpf: diabetic, 2.28 [0.16]; idio-
pathic, 2.53 [0.47]; controls, 6.05 [0.62]; P=.004). Overall immune cell population 
(CD45) was unchanged but there was a loss of anti- inflammatory macrophages 
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1  | INTRODUCTION
Human diabetic and idiopathic gastroparesis and animal models of 
delayed gastric emptying are characterized by the loss of interstitial 
cells of Cajal (ICC) as a key cellular abnormality. Previous studies from 
the NIH Gastroparesis Clinical Research Consortium (GpCRC) have 
shown a 50% loss of ICC in gastric body muscularis and ultrastruc-
tural damage in remaining ICC in the majority of patients with gastro-
paresis.1,2 Other studies also report significant or complete absence 
of ICC networks.3,4 The loss of ICC immunoreactivity (ir) correlated 
with diabetes severity.5 Additional cellular abnormalities include 
loss or damage of nerves or neurons in a subset of patients raising 
the possibility of a common underlying mechanism of damage to the 
cell types that regulate gastrointestinal motility.1,2,4 More recently, 
macrophages have been shown to be critical in the pathophysiology 
of gastroparesis in animal models. In the non- obese diabetic (NOD) 
mouse model, development of diabetes was associated with appear-
ance of anti- inflammatory (M2 or alternatively activated, CD206 ir) 
macrophages. However, gastric emptying delay was evident only after 
M2 macrophages phenotypically switched to pro- inflammatory (M1 
or classically activated) macrophages6 and ICC were lost. In another 
study using diabetic, macrophage- deficient CSF1op/op mice, absence 
of muscle layer macrophages was protective against the development 
of delayed gastric emptying.7 These data suggest that interactions be-
tween the innate immune system, specifically macrophages, and ICC 
and the neuromuscular apparatus may be central in the pathophysiol-
ogy of human gastroparesis.8
In our previous study, we provided evidence supporting the ex-
istence of this paradigm in the gastric body of patients with diabetic 
gastroparesis where loss of ICC correlated with the number of M2 
macrophages.9 It was not apparent that the observed changes could 
be found in other regions of the stomach that are also important for 
gastric motility such as the antrum. Coordinated activity in the an-
trum is required for grinding of food particles and passage of food 
into the duodenum. Postprandial antral hypomotility was observed 
in over 60% of patients with gastroparesis, and was associated with 
a significantly lower motility index in patients with autonomic neu-
ropathy.10 Duplex sonography showed decreased frequency of 
coordinated antroduodenal contractions and reduced anterograde 
transpyloric flow in gastroparetic patients with autonomic neuropa-
thy.11 Gastroparesis patients had a reduced number of antral waves 
≥6 cm in duration which correlated with gastric emptying and im-
proved in response to cisapride, a prokinetic agent.12 In animal mod-
els, ICC are more affected in the antrum than the body13,14 and gastric 
antral ICC and stem cell factor expression were found to be reduced 
in streptozocin- induced diabetic mice.15 Reduced ICC numbers, struc-
tural ICC degeneration, and reduced enteric nerves limited to gastric 
antrum was associated with delayed gastric emptying in this model.16
The cellular changes in gastric antrum in human gastroparesis are 
not well known. Therefore, the aim of this study was to determine: (i) if 
CD206- positive macrophages shown to protect against cellular damage 
in animal models of gastroparesis are also decreased in the antrum of 
humans with gastroparesis, (ii) whether there are changes in other cell 
types known to be important for gastric motility and (iii) the relation-
ship of these cellular findings with clinical symptoms of gastroparesis.
2  | METHODS
2.1 | Specimens
Full thickness gastric antrum biopsies were obtained from 11 diabetic, 
six idiopathic gastroparesis patients undergoing implantation of a gas-
tric electrical stimulator, and from five controls without diabetes or 
gastroparesis undergoing obesity surgery. All patients were >18 years 
of age with symptoms of at least 12- week duration, delayed gastric 
emptying on scintigraphy (>60% retention at 2 hours or >10% reten-
tion at 4 hours), and no evidence of obstruction. Exclusion criteria in-
cluded presence of active inflammatory bowel disease, eosinophilic 
gastroenteritis, neurological conditions, acute liver or renal failure, 
and history of total or subtotal gastric resection. Tissue collection was 
done in standardized fashion with established protocols by the partici-
pating sites of the GpCRC and tissue was shipped to the histology core 
at Mayo Clinic. Tissue was fixed in 4% paraformaldehyde and cryopre-
served until further use. All gastroparesis patients provided informed 
consent for procurement and use of gastric tissue at the clinical sites 
of GpCRC. All control tissues were obtained in a de- identified fashion 
with patient consent at Mayo Clinic in an IRB- approved protocol.
(CD206) in circular muscle (diabetic, 3.87 [0.32]; idiopathic, 4.16 [0.52]; controls, 6.59 
[1.09]; P=.04) and myenteric plexus (diabetic, 3.83 [0.27]; idiopathic, 3.59 [0.68]; 
 controls, 7.46 [0.51]; P=.004). There was correlation between the number of ICC and 
CD206- positive cells (r=.55, P=.008). Enteric nerves (PGP9.5) were unchanged: 
 diabetic, 33.64 (3.45); idiopathic, 41.26 (6.40); controls, 46.80 (6.04).
Conclusion: Loss of antral CD206- positive anti- inflammatory macrophages is a key 
feature in human gastroparesis and it is associates with ICC loss.
K E Y W O R D S
enteric nervous system, gastrointestinal motility, immune cells, interstitial cells of Cajal, 
macrophages
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2.2 | Light microscopy
Twelve micrometer sections were cut for H&E, trichrome to assess 
fibrosis, and immunofluorescence for enteric nervous system (ENS), 
ICC, and immune cell markers. Protein gene product 9.5 (PGP9.5) 
was used as general marker for nerves, neuronal nitric oxide synthase 
(nNOS), vasoactive intestinal peptide (VIP) for the inhibitory com-
ponent, and substance P for the excitatory component of the ENS. 
Tyrosine hydroxylase (TH) was used to assess extrinsic sympathetic 
innervation, Kit to assess ICC, CD45 to assess overall immune cells, 
and CD206 to assess M2 (alternatively activated) macrophages. 
Details on antibodies are provided in Table S1.
2.3 | Quantification
All quantitative assessment was done in a blinded fashion. For PGP9.5 
ir fibers (circular muscle), nNOS ir neurons (myenteric plexus) and fibers 
(circular muscle), VIP ir fibers (circular muscle), substance P ir fibers (circu-
lar muscle), TH ir (myenteric plexus), and CD45 and CD206 ir cell bodies 
(myenteric plexus and circular muscle), two non- adjacent sections were 
analyzed per participant. Approximately, 20–23 images were randomly 
collected per patient at 40× magnification. These were then manually 
counted to identify positively staining nerve fibers and cell bodies. For 
nerve fibers, we quantified the number of distinct fluorescent structures 
with a fiber- like morphology, that is, a connected line of immunofluores-
cent pixels. We saw no evidence that the shape of the fiber paths are 
different between diseased and normal tissue and the counts provided 
include fibers that are broken up more than once in tissues from both 
groups. Each field was 0.0367 mm2 in size. For quantitative assessment 
of ICC bodies (circular muscle), 2–3 non- adjacent sections were analyzed 
per patient. ICC cell bodies were counted from 38 to 40 fields per patient 
at 40× magnification. An ICC body was defined as a Kit- positive struc-
ture with a DAPI- positive nucleus within the structure. Mast cells were 
excluded by their larger, more circular appearance and brighter fluores-
cence. The number of images needed for all markers was determined 
from previous data from quantification from gastric body.1
2.4 | Gastric emptying
Gastric emptying study was scintigraphy- based using a low- fat egg 
white meal with imaging at 0, 1, 2, and 4 hours after meal ingestion 
using the standardized protocol to estimate percent gastric retention. 
This protocol ensures standardized information about delayed gastric 
emptying across all participating sites.17
2.5 | Statistical analysis
Quantitative data for c- Kit, PGP, nNOS, VIP, substance P, TH, CD45- 
ir, and CD206- ir cell bodies are represented as mean±SEM. Statistical 
significance was determined using the two sided- non- parametric 
Mann- Whitney test. Simple Pearson’s correlation analysis assum-
ing non- parametric distribution was done to relate the histological 
markers (as measured) with each other and with symptom severity 
(overall Gastroparesis Cardinal Symptom Index, GCSI). Spearman r 
values were reported. A P<.05 was considered statistically significant. 
Exact P- values were used and these were not corrected for multiple 
comparisons. All statistical analyses were carried out using GraphPad 
4 software (GraphPad software Inc., La Jolla, CA, USA).
3  | RESULTS
3.1 | Demographic profile
Table 1 lists the demographic profile of diabetic and idiopathic gas-
troparesis patients. Three of the five controls were females and the 
median age was 51 years (range 39–65 years). The BMI was higher in 
diabetic gastroparesis as compared to the idiopathic gastroparesis pa-
tients. Remaining demographic characteristics, gastric emptying, and 
symptom severity scores (average GCSI and sub- scores of nausea, 
fullness, and bloating) were similar in the two groups.
3.2 | Gross morphology and assessment of fibrosis
The H&E staining showed normal histology of gastric antrum in all 
samples and trichrome staining showed no evidence of fibrosis in the 
gastroparesis biopsies.
3.3 | Interstitial cells of Cajal
Both diabetic and idiopathic gastroparesis patients showed significant 
loss of ICC. Diabetic and idiopathic gastroparesis patients had a 62% and 
58% drop in ICC counts as compared to the healthy controls, respec-
tively (Mean [SEM] for diabetic gastroparesis: 2.28 [0.16]; idiopathic gas-
troparesis 2.53 [0.47]; controls 6.05 [0.62], P- ANOVA=.004) (Figure 1). 
No difference was noted between diabetic and idiopathic gastroparesis 
(Table 2). The loss of ICC was uniform throughout the circular muscle.
3.4 | Enteric nervous system markers
The overall ir for enteric nerves (PGP9.5) was unchanged 
(Mean [SEM] for diabetic gastroparesis: 33.64 [3.45]; idiopathic 
Key points
• Macrophages play a critical role in development of de-
layed gastric emptying in animal models. Their role in 
human gastroparesis is unclear.
• There is a significant loss of CD206 positive anti-inflam-
matory macrophages in gastric antrum of patients with di-
abetic and idiopathic gastroparesis and this correlates with 
the ICC loss, the key cellular abnormality in gastroparesis.
• Interactions between innate immune cells and other cell 
types that regulate gastrointestinal motility are important 
in pathophysiology of gastroparesis and should be further 
studied.
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gastroparesis 41.26 [6.40]; controls 46.80 [6.04], P- ANOVA=.13) 
(Figure S1). Excitatory nerve ir (substance P ir) was unchanged (dia-
betic gastroparesis: 26.13 [2.41]; idiopathic gastroparesis 29.48 
[3.87]; controls 21.67 [1.38], P- ANOVA=.3). Inhibitory nerve ir was 
unchanged for nNOS ir (diabetic gastroparesis: 27.15 [2.95]; idio-
pathic gastroparesis: 35.43 [4.75]; controls 26.57 [3.90]) and VIP ir 
(diabetic gastroparesis: 20.65 [2.19]; idiopathic gastroparesis: 26.32 
[2.83]; controls 22.37 [3.89]). The nNOS ir neurons in myenteric 
plexus was unchanged (diabetic gastroparesis: 1.85 [0.12]; idiopathic 
gastroparesis: 2.00 [0.34]; controls 2.07 [0.30]). Extrinsic sympa-
thetic nerves (TH) were unchanged in both diabetic and idiopathic 
gastroparesis as compared to healthy controls (diabetic gastropa-
resis: 32.50 [4.01]; idiopathic gastroparesis: 41.57 [4.69]; controls 
38.32 [4.67]).
3.5 | Immune cells and CD206 macrophages
The overall immune cell population was quantified with CD45 
ir and was not different in diabetic and idiopathic gastroparesis 
when compared with healthy controls in circular muscle (Mean 
[SEM] for diabetic gastroparesis: 13.82 [1.09]; idiopathic gastro-
paresis 11.38 [0.54]; controls 19.25 [4.05], P=.07) and myenteric 
plexus (Mean [SEM] for diabetic gastroparesis: 14.72 [0.61]; idi-
opathic gastroparesis 18.34 [2.24]; controls 22.90 [3.15], P=.09) 
(Figure S2).
CD206 ir (M2 or anti- inflammatory) macrophages were markedly 
decreased in both diabetic and idiopathic gastroparesis. In circular 
muscle, there was a 41% ir decrease in diabetic and 37% ir decrease 
in idiopathic gastroparesis (Mean [SEM] for diabetic gastroparesis: 
3.87 [0.32]; idiopathic gastroparesis 4.16 [0.52]; controls 6.59 [1.09], 
P=.04). In myenteric plexus, there was a 49% ir decrease in diabetic 
gastroparesis and 52% decrease in myenteric plexus ir (Mean [SEM] 
for diabetic gastroparesis: 3.83 [0.27]; idiopathic gastroparesis 3.59 
[0.68]; controls 7.46 [0.51], P=.004) (Figure 2).
3.6 | Correlation between CD206 
macrophages and ICC
There was a positive correlation between the CD206 ir cells and ICC 
(r=.55, P=.008, n=22) (Figure 3).
F IGURE  1 c- Kit immunoreactivity (circular muscle) in control (A), diabetic gastroparesis, Db Gp (B) and idiopathic gastroparesis, Id Gp (C) 
showing significant ICC loss in both diabetic and idiopathic gastroparesis. Arrowhead represents an ICC and arrow represents a mast cell in the 
field. ICC, interstitial cells of Cajal
(A) (B) (C)
Diabetic gastroparesis 
(n=11)
Idiopathic gastroparesis 
(n=6)
Age (median, range) 36, 22–56 years 34, 20–60 years
Sex (n, females) 8 5
BMI (mean±SEM) 26.3±1.4 20.5±1.6*
Diabetes
Type Type I- 7, Type 2- 4
Duration (mean±SEM) 16.8±3.8 years –
Gastric emptying
(% Retention at 4 hrs)
(Mean±SEM)
32.4±6.4% 44.0±11.9%
GCSI, overall 3.7±0.3 3.0±0.3
Nausea 3.9±0.3 2.7±0.5
Fullness 3.8±0.3 4.0±0.3
Bloating 3.3±0.5 2.4±0.9
GCSI, Gastroparesis Cardinal Symptom Index.
*P<.05.
TABLE  1 Demographic characteristics, 
clinical symptoms, and gastric emptying of 
patients with diabetic and idiopathic 
gastroparesis
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3.7 | Correlation of cellular changes with 
clinical symptoms
There was no correlation between the ICC counts and average GCSI 
(r=.15, P=.6). There was no correlation between the circular muscle 
CD206 ir cells and average GCSI (r=−.23, P=.4). Similarly, there was no 
correlation between the myenteric plexus CD206 ir cells and average 
GCSI (r=−.26, P=.4) (Figure S3).
3.8 | Correlation of ICC counts with gastric emptying
There was no correlation between the ICC counts and percent gastric 
retention at 4 hours in diabetic (r=.10, P=.7) or idiopathic gastropare-
sis (r=.17, P=.8) (Figure S4).
4  | DISCUSSION
The pathogenesis of gastroparesis has been obscure but recent ex-
perimental studies support an emerging paradigm in which a shift to a 
pro- inflammatory macrophage phenotype drives loss of ICC and de-
layed gastric emptying.8 This manuscript highlights a number of simi-
larities with the findings in animal models but also some differences. 
Firstly, this study confirms that the major gastrointestinal cell type as-
sociated with the loss of gastric motility in both diabetic and idiopathic 
gastroparesis is the ICC. This finding has now been reported by several 
laboratories and appears to involve both the body and antrum of the 
human stomach.1,18,19 In a study of patients with refractory gastropa-
resis, ICC loss was present in both diabetic and idiopathic gastropare-
sis but more profound in idiopathic.18 Depleted antral ICC correlated 
with abnormalities on electrogastrogram and poor symptomatic re-
sponse to gastric electric stimulation.20 The ICC loss observed in the 
gastric antrum (>60% loss) in this study is more profound than our 
previous report in the gastric body (35%–45% loss).1 These data rep-
licate findings from mouse models observing a greater ICC loss in the 
gastric antrum than the body.21–23 Previously, we have demonstrated 
significant inverse correlation between ICC counts and 4 hours per-
cent gastric retention in gastric body tissue from diabetic gastropa-
resis patients (50% diabetic gastroparetics had <3 ICC/field).24 The 
more profound nature of ICC loss in gastric antrum (10/11 diabetic 
gastroparetics had <3 ICC/field) may explain lack of correlation with 
gastric emptying because beyond a critical loss of ICC, the association 
with gastric physiology is potentially lost.
The original finding of enteric nerves being preserved in the gas-
tric body in diabetic and idiopathic gastroparesis patients enrolled 
in the GpCRC appears to extend to the gastric antrum as well.1 
Immunoreactivity for PGP9.5, a general marker for enteric nerves and 
neurons was found to be unchanged in gastroparesis. Similarly, im-
munoreactivity for excitatory nerves, inhibitory nerves, and extrinsic 
sympathetic innervation was also unchanged in gastric antrum. We 
did not find an association between GCSI scores and ICC or CD206 ir 
numbers highlighting the multifactorial central and peripheral mech-
anisms that sustain symptom generation once established by the pri-
mary defect.
TABLE  2 Quantitative immunolabeling data for patients with diabetic gastroparesis, idiopathic gastroparesis, and controls. A HPF represents 
0.0367 mm2
Cellular marker
Diabetic gastroparesis  
(n=11, mean/HPF±SEM)
Idiopathic gastroparesis  
(n=6, mean/HPF±SEM)
Controls (n=5, mean/
HPF±SEM)
ANOVA 
(P- value)
c- Kit 
(Circular Muscle)
2.28±0.16 2.53±0.47 6.05±0.62 .004
CD45 
(Circular Muscle)
13.82±1.09 11.38±0.54 19.25±4.05 .07
CD45 
(Myenteric plexus)
14.72±0.61 18.34±2.24 22.90±3.15 .09
CD206 
(Circular Muscle)
3.87±0.32 4.16±0.52 6.59±1.09 .04
CD206 
(Myenteric plexus)
3.83±0.27 3.59±0.68 7.46±0.51 .004
PGP 
(Circular Muscle)
33.64±3.45 41.26±6.40 46.80±6.04 .13
Substance P 
(Circular Muscle)
26.13±2.41 29.48±3.87 21.67±1.38 .25
VIP 
(Circular Muscle)
20.65±2.19 26.32±2.83 22.37±3.89 .33
n NOS Neurons 
(Myenteric plexus)
1.85±0.12 2.00±0.34 2.07±0.30 .82
n NOS 
(Circular Muscle)
27.15±2.95 35.43±4.75 26.57±3.90 .27
Tyrosine Hydroxylase 
(Myenteric plexus)
32.50±4.01 41.57±4.69 38.32±4.67 .30
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The involvement of macrophages in the development of delayed 
gastric emptying was initially described in NOD mice. At the onset 
of diabetes, anti- inflammatory CD206- positive M2 macrophages 
populate the muscle wall of the stomach of NOD mice, accounting 
for nearly 80% of all macrophages.6 However, mice that go on to 
develop delayed gastric emptying lost their CD206- positive M2 mac-
rophages and expressed M1 macrophages. In contrast to the mouse, 
the human stomach is populated by a mixture of both CD206- positive 
and - negative macrophages and rather than absolute loss of a type, 
the relative number appears to be more important. Nevertheless, our 
findings are similar in showing a disproportionate loss of CD206 mac-
rophages in patients with gastroparesis. In the antrum, there was a 
40%–45% percent loss of CD206 ir cells in circular muscle and >50% 
loss in the myenteric plexus. This is in contrast to our previous study 
on gastric body where we did not see an absolute loss of CD206 ir 
macrophages and suggests a more severe defect in the antrum com-
pared to the body. However, as in this study on the antrum, there was 
a negative correlation between CD206 macrophage counts and ICC 
numbers.
Contrary to the previous reports of an immune infiltrate in gast-
roparesis, in this study we did not find evidence for a classical inflam-
matory cell infiltrate as demonstrated by the normal numbers of CD45 
ir cells in this study. The immune dysfunction in gastroparesis there-
fore appears to be a macrophage- specific process, characterized by 
a relative or absolute loss of CD206 ir, anti- inflammatory cells. It has 
been more difficult to examine the changes in the pro- inflammatory 
M1 macrophage phenotype in humans. As compared to mouse mac-
rophages, there is a paucity of markers for macrophage populations in 
F IGURE  2 CD206 ir (circular muscle) in control (A), diabetic gastroparesis, Db Gp (B), and idiopathic gastroparesis, Id Gp (C); CD206 ir 
(myenteric plexus) in control (D), diabetic gastroparesis (E), and idiopathic gastroparesis (F), both demonstrating loss of M2 (anti- inflammatory) 
macrophages (represented by arrowheads) in diabetic and idiopathic gastroparesis
(A) (B) (C)
(D) (E) (F)
F IGURE  3 Correlation of ICC (circular muscle) and CD206 ir cells 
(circular muscle) showing significant correlation between ICC loss and 
loss of anti- inflammatory macrophages. ICC, interstitial cells of Cajal
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humans.25 In mice, resident mucosal and lamina propria macrophages 
are characterized by the expression of F4/80, CD64, major histo-
compatibility complex II (MHCII), CD11c, and CX3CR1.26 Classically 
activated macrophages (M1) can be characterized by high levels of 
pro- inflammatory cytokines such as interleukin 6 (IL6), inducible ni-
tric oxide synthase (iNOS, NOS2), IL1β, and tumor necrosis factor- α 
(TNFα).26,27 Alternatively, activated macrophages (M2) have lower lev-
els of C- C chemokine receptor type 2 (CCR2) and CD62L and have 
an anti- inflammatory signature with increased levels of interleukin 10 
(IL10), heme oxygenase- 1 (HO1), and CD20. Most of these markers 
are either not present in human gastrointestinal macrophages or have 
not been studied. CD206 is a well- studied marker of anti- inflammatory 
M2- like macrophages and is also expressed in human macrophages 
but arginase- 1 and Ym1 are examples of other proteins that are ex-
pressed in mouse but not human M2 macrophages.28 There are cur-
rently no well- defined markers for human pro inflammatory M1- like or 
overall macrophages in the gastrointestinal tract. For example, iNOS 
is robustly expressed in mouse macrophages in inflammation but is 
epigenetically repressed in human macrophages.29 Further studies are 
therefore necessary to identify and validate novel biomarkers for these 
cell types in human gastric muscularis propria and to count them ei-
ther by a single or by a combination of antigenic signatures. Our con-
trol tissues are derived from obese subjects, however, previously we 
have found no changes in kit, PGP9.5, and CD45 ir from gastric body 
tissues of obese and non- obese subjects making it unlikely that obe-
sity has significant impact on gastric ENS and immune cell markers.1
Taken together with the results of experimental studies in mice, 
the finding that CD206- positive macrophages are decreased in gas-
troparesis in the antrum suggests that targeting macrophage polar-
ization represents an attractive therapeutic strategy. In NOD mice, 
up- regulating HO1 in gastric muscularis CD206 macrophages reverses 
delayed gastric emptying.30 Carbon monoxide, the product of HO1 ac-
tivity, has the same effect.31 IL10 also increases HO1 expression in 
the gastric body of diabetic NOD mice and recovers delayed gastric 
emptying, electrical slow wave abnormalities, and ICC networks.32 
This is consistent with the known effects of IL10 in suppressing pro- 
inflammatory macrophages and increasing anti- inflammatory macro-
phages.33 IL10 is known to be safe for use in humans.34 The recent 
demonstration that macrophages are necessary for development of 
delayed gastric emptying in diabetic mice7 also suggests that neu-
tralizing the pro- inflammatory cytokines generated by convention-
ally activated, M1- like macrophages may also serve as a treatment 
opportunity.
In summary, our findings show that the major gastrointestinal 
cellular defect in the antrum of patients with diabetic and idiopathic 
gastroparesis is loss of ICC. Secondly, there is a profound loss of anti- 
inflammatory macrophages in the antrum of both diabetic and idio-
pathic gastroparesis patients. Further, there is a correlation between 
ICC and CD206 ir macrophage numbers suggesting that ICC loss may 
be the result of loss of the anti- inflammatory macrophage subtype. 
Finally, there is no change in the density of the nerves in the gastric 
antrum in either diabetic or idiopathic gastroparesis. Overall, these 
findings provide pathophysiological insights for human gastroparesis 
being driven by interactions between the innate immune system and 
ICC and provide a potential rationale for targeting macrophages and 
the associated inflammatory milieu for the treatment of gastroparesis.
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